Member Info for howdlep

_Mr_Big

If that is your delayed buy (466k @ 0.85p) that's a very good price?

Will be interesting to see what happens next.

One 107k buy ticks the bid up to 0.6p. But what is interesting, is that we are now 1 v 3 with one MM moved up to 1.1p. I am presuming that is the same one, but cannot verify on my screen.

It just needs a few more buys and we will be off and running.

Linandy1,

Purely a defensive MM spread. They are establishing a true offer price. If those buys come in, they will slowly raise the bid. What they don't want to do, is offer too highly, then see a large sell come. All about managing the NMS.

Phil

L2 is very strong. Currently 4 (1.2m) v 4 (1.2m) albeit with defensive spread. That will change shortly, if a few buys follow.

This looks to be very good news. More of the same Trevor!

I agree. TB will be judged on the share price but he must not place below 1p.

Just think about it for a moment. Let's say he raised £300k at 0.5p. That would required the issuance of 60m shares. That is not acceptable to me.

The Board need to raise the share price to circa 1.5p and maybe place at 1p. To do that, revenues have to grow substantially.

That said, a larger placing may be acceptable for an acquisition, if it was immediately earnings enhancing.

Red,

The Board has already stated the "the company projects a small profit for the current year and expects sufficient working capital without needing to raise additional funds".

Whilst you are right that TB may want to obtain cheaper shares via a CLN, the nominal reduction was needed to ensure that the Kirkstall CLN could be converted into shares at 0.75p. Otherwise, a separate GM would have been required.

I was not happy with the Kirkstall RNS, as it stated that the settlement could be made at 0.75p or a lower placing.

Trevor Brown should be under no doubt that his performance is being watched by all shareholders in this financial year. Should a placing be achieved under 1p, I would hope/expect him to be voted off the Board at next years AGM. Remember, he is up for re election then.

The Board must achieve far greater revenue growth across all areas of the business. I will expect confirmation of that in the Interims.

In the meantime, let us hope new investors appear, wanting to take this company forward. Physiomics is an example of what can be done.

Kind regards

Phil

L2 strengthening.

1 300k 0.55 v 0.65 300k 1

1 300k 0.50 v 0.70 300k 1

1 300k 0.45 v 0.90 300k 1

1 300k 0.40 v 1.00 300k 1

1 300k 0.30 v 1.30 300k 1 (effectively not been quoting for quite a while)

All down to NMS though and volume going through as always.

Very good to see a 833k premium buy at 0.625p.

Now let's see if there is a follow through, both today and in the lead up to the AGM.

Pleased to see that a revised AGM Notice RNS has now been released. This will protect all shareholders from any future heavily discounted placing and ensure AGM/GM consultation before any major event takes place. Please note, I was not aware of any plans for a discounted placing. Indeed, the company has made it clear in the Finals that no placing was needed. Hopefully, that continues for the financial year, as revenues grow across all areas of the business. A small profit would be very welcome.

Thanks Tony

Can a fellow shareholder provide me with a current email address for Michael Schmainda, as previous attempts to connect on Linkedin have not been successful?

If people are reluctant to provide this information on this forum (I seem to remember it previously being posted here), I can be contact by DM on X via @howdlep.

Thanks in advance

Phil

Dear All,

Here is information relating to the forthcoming AGM:-

i) 2026 AGM Notice

https://www.ibailtd.com/wpibai/wp-content/uploads/2026/05/2026-Imaging-Biometrics-Notice-of-AGM-WEB.pdf

ii) 2026 AGM Proxy

https://www.ibailtd.com/wpibai/wp-content/uploads/2026/05/2026-Imaging-Biometrics-Proxy-WEB.pdf

I would ask that ALL shareholders print off these documents immediately.

I cannot comment further at this stage. However, I will do so if no further RNS is issued at 7am tomorrow morning.

Kind regards

Philip Howdle

It is 1/20th of a penny. I have already sent a message to TB asking if it is a typo.

Changing the nominal value to 0.05p facilitates capital raising via a placing, even though the company has indicated that one is not needed in the current year. Having said that, it will allow the company to settle debts or complete acquisitions, such as the recent Kirkstall Limited deal by issuing shares instead of using scarce cash. This was to be at the pre sub-division price of 0.75p.

Again, this answer may vary with IBAI being Jersey registered.

A good start to the day, for which AI summarises as:-

Imaging Biometrics Limited announced that its subsidiary, Kirkstall Limited, has been awarded a BBSRC/NC3Rs grant to partner with Nottingham Trent University on developing a glioblastoma 'tumour on a chip' model. This research aims to create a more accurate, human-relevant platform for testing glioblastoma treatments, potentially improving drug development success rates and reducing animal testing. The company views this grant as validation of its acquisition strategy, integrating Kirkstall's organ-on-a-chip technology with Imaging Biometrics' MRI analysis software to address glioblastoma from research to patient care.

In addition, Trevor has added to his Truetide holding. Looks like he wants to get their share price above 2p to increase their funding options.

Time also for the IBAI board to buy IBAI shares on the open market, particularly the new director.

Can someone post a link to the AGM resolutions once it is available for viewing.

It is highly important that the current board back the plan to profitability in financial year 2026. Whilst I appreciate that the Truetide/TB concert party holding is close to 30%, which makes it difficult to add shares on the open market, I want to see our board highly incentivised with their AGM options. Under no circumstances should director fees be cut, if they are then to receive at the money options. After all, it was the TB family sale of shares that was largely responsible for the big fall in the share price.

The days of cancelling historical options and replacing them with at the money options, must also be truly over. If not, I can see a PYC type overhaul taking place.

I wonder whether MS and/or KS are considering an open market purchase, given no placing is required?

Tyke,

Yes I saw your comment yesterday re the accounts being published this week. But why wait right up to 30/4 or 1/5 before publication, unless there is going to be additional news?

Not long to wait now.

Phil

I wonder whether we might have an RNS tomorrow morning before 8am, suspending the shares pending a major financial announcement?

I would be very happy to be told that there have been multiple discussions in relation to the purchase of our company, which may or may not lead to an offer being made for the entire share capital of IBAI. Shareholders need not do anything at this stage.

Here's hoping!

Thanks Corryvreckan1

Thanks Tyke.

I presumed, as Imaging Biometrics (IBAI) has a Main market listing, annual results are required to be delivered on or before 30 April 2026, otherwise the shares will be suspended. This would remain the case, until they are released, for a maximum of six months. Then the shares would be delisted.

Does this apply for companies registered in Jersey?

Phil